CLARIEYE Trademark

Trademark Overview

On Monday, February 10, 2020, a trademark application was filed for CLARIEYE with the United States Patent and Trademark Office. The USPTO has given the CLARIEYE trademark a serial number of 88790966. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, July 17, 2024. This trademark is owned by Bayer HealthCare LLC. The CLARIEYE trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparations
clarieye

General Information

Serial Number88790966
Word MarkCLARIEYE
Filing DateMonday, February 10, 2020
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Goods and ServicesOphthalmic preparations
Pseudo MarkCLARI EYE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer HealthCare LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWhippany, NJ 07981
Party NameBayer HealthCare LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWhippany, NJ 07981

Trademark Events

Event DateEvent Description
Thursday, February 13, 2020NEW APPLICATION ENTERED
Thursday, February 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 29, 2020ASSIGNED TO EXAMINER
Wednesday, April 29, 2020SUSPENSION LETTER WRITTEN
Wednesday, April 29, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, April 29, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 25, 2020ASSIGNED TO LIE
Wednesday, November 25, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 20, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 30, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 12, 2023SOU EXTENSION 1 FILED
Wednesday, July 12, 2023SOU EXTENSION 1 GRANTED
Friday, July 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU EXTENSION 2 FILED
Wednesday, November 29, 2023SOU EXTENSION 2 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 17, 2024SOU EXTENSION 3 FILED

Related Keywords

clarieye preparations ophthalmic